دورية أكاديمية

Impact of Prior Lines of Systemic Therapy (PST) on the Efficacy Of Cemiplimab, a Human Monoclonal Anti–PD-1, in Patients (PTS) with Advanced Cutaneous Squamous Cell Carcinoma (CSCC)

التفاصيل البيبلوغرافية
العنوان: Impact of Prior Lines of Systemic Therapy (PST) on the Efficacy Of Cemiplimab, a Human Monoclonal Anti–PD-1, in Patients (PTS) with Advanced Cutaneous Squamous Cell Carcinoma (CSCC)
المؤلفون: Rischin, D., Khushalani, N.I., Schmults, C.D., Guminski, A., Chang, A.L.S., Lewis, K.D., Lim, A.M., Hernandez-Aya, L., Hughes, B.G.M., Schadendorf, D., Hauschild, A., Stankevich, E., Booth, J., Li, S., Chen, Z., Desai, J., Lowy, I., Fury, M.G., Migden, M.R.
المصدر: Annals of Oncology ; volume 30, page xi35-xi36 ; ISSN 0923-7534
بيانات النشر: Elsevier BV
سنة النشر: 2019
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Oncology, Hematology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1093/annonc/mdz451.006
الإتاحة: https://doi.org/10.1093/annonc/mdz451.006Test
https://api.elsevier.com/content/article/PII:S0923753420344847?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753420344847?httpAccept=text/plainTest
http://academic.oup.com/annonc/article-pdf/30/Supplement_11/mdz451.006/31507865/mdz451.006.pdfTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/
رقم الانضمام: edsbas.D9966AFD
قاعدة البيانات: BASE